Biosimilars for chronic plaque psoriasis: a 2026 update
Expert Review of Clinical Pharmacology · 04.05.2026 · 19 (5) · 447-455
DOI: 10.1080/17512433.2026.2667342 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Clinical Pharmacology, online erschienen am 03.05.2026. Verfasst von Martina Maurelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Biosimilar Pharmaceuticals, Psoriasis, Dermatologic Agents. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union’s H2020 Research and Innovation Program, European Union—Next Generation EU—PNRR, Italian Ministry of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
Förderung
- European Union’s H2020 Research and Innovation Program
- European Union—Next Generation EU—PNRR
- Italian Ministry of Health
Zitieren
APA
Maurelli, M., Danese, A., Gisondi, P., & Girolomoni, G. (2026). Biosimilars for chronic plaque psoriasis: a 2026 update. Expert Review of Clinical Pharmacology, 19(5), 447-455. https://doi.org/10.1080/17512433.2026.2667342
Vancouver
Maurelli M, Danese A, Gisondi P, Girolomoni G. Biosimilars for chronic plaque psoriasis: a 2026 update. Expert Review of Clinical Pharmacology. 2026;19(5):447-455. doi:10.1080/17512433.2026.2667342
BibTeX
@article{Maurelli2026,
author = {Maurelli, Martina and Danese, Andrea and Gisondi, Paolo and Girolomoni, Giampiero},
title = {Biosimilars for chronic plaque psoriasis: a 2026 update},
journal = {Expert Review of Clinical Pharmacology},
year = {2026},
volume = {19},
number = {5},
pages = {447--455},
doi = {10.1080/17512433.2026.2667342}
}
EUVIMED